The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, N. J.
Right arrow Articles by Rennick, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, N. J.
Right arrow Articles by Rennick, D. M.
The Journal of Immunology, 1998, 161: 3143-3149.
Copyright © 1998 by The American Association of Immunologists

IL-12, But Not IFN-{gamma}, Plays a Major Role in Sustaining the Chronic Phase of Colitis in IL-10-Deficient Mice1

Natalie J. Davidson2,*, Susan A. Hudak*, Robin E. Lesley*, Satish Menon*, Michael W. Leach{dagger} and Donna M. Rennick*

* DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, CA 94304; and {dagger} Schering-Plough Research Institute, Lafayette, NJ 07848

IL-10-deficient (IL-10-/-) mice develop chronic enterocolitis mediated by CD4+ Th1 cells producing IFN-{gamma}. Because IL-12 can promote Th1 development and IFN-{gamma} production, the ability of neutralizing anti-IL-12 mAb to modulate colitis in IL-10-/- mice was investigated. Anti-IL-12 mAb treatment completely prevented disease development in young IL-10-/- mice. Treatment of adult mice resulted in significant amelioration of established disease accompanied by reduced numbers of mesenteric lymph node and colonic CD4+ T cells and of mesenteric lymph node T cells spontaneously producing IFN-{gamma}. In contrast, anti-IFN-{gamma} mAb had minimal effect on disease reversal, despite a significant preventative effect in young mice. These findings suggested that IL-12 sustains colitis by supporting the expansion of differentiated Th1 cells that mediate disease independently of their IFN-{gamma} production. This conclusion was supported by the finding that anti-IL-12 mAb greatly diminished the ability of a limited number of CD4+ T cells expressing high levels of CD45RB from diseased IL-10-/- mice to expand and cause colitis in recombination-activating gene-2-/- recipients, while anti-IFN-{gamma} mAb had no effect. Furthermore, IL-12 could support pathogenic IL-10-/- T cells stimulated in vitro in the absence of IL-2. While these studies show that IL-12 plays an important role in sustaining activated Th1 cells during the chronic phase of disease, the inability of anti-IL-12 mAb to abolish established colitis or completely prevent disease transfer by Th1 cells suggests that additional factors contribute to disease maintenance.




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. Mane, E. Pedrosa, V. Loren, I. Ojanguren, L. Fluvia, E. Cabre, G. Rogler, and M. A. Gassull
Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10-Deficient Mice
J. Nutr., March 1, 2009; 139(3): 603 - 610.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
Int. Immunol., June 1, 2008; 20(6): 739 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. J. Albert and J. S. Marshall
Aging in the absence of TLR2 is associated with reduced IFN-{gamma} responses in the large intestine and increased severity of induced colitis
J. Leukoc. Biol., April 1, 2008; 83(4): 833 - 842.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Song, C. Matsuda, Y. Kai, T. Nishida, K. Nakajima, T. Mizushima, M. Kinoshita, T. Yasue, Y. Sawa, and T. Ito
A Novel Sphingosine 1-Phosphate Receptor Agonist, 2-Amino-2-propanediol Hydrochloride (KRP-203), Regulates Chronic Colitis in Interleukin-10 Gene-Deficient Mice
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 276 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. R. Etling, S. Davies, M. Campbell, R. W. Redline, P. Fu, and A. D. Levine
Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10-deficient (IL-10 / ) mice
J. Leukoc. Biol., August 1, 2007; 82(2): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Wada, R. Lu, D. Zhou, J. Chu, T. Przewloka, S. Zhang, L. Li, Y. Wu, J. Qin, V. Balasubramanyam, et al.
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
Blood, February 1, 2007; 109(3): 1156 - 1164.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. C. Kullberg, D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, et al.
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis
J. Exp. Med., October 30, 2006; 203(11): 2485 - 2494.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Toichi, G. Torres, T. S. McCormick, T. Chang, M. A. Mascelli, C. L. Kauffman, N. Aria, A. B. Gottlieb, D. E. Everitt, B. Frederick, et al.
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
J. Immunol., October 1, 2006; 177(7): 4917 - 4926.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Becker, H. Dornhoff, C. Neufert, M. C. Fantini, S. Wirtz, S. Huebner, A. Nikolaev, H.-A. Lehr, A. J. Murphy, D. M. Valenzuela, et al.
Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis.
J. Immunol., September 1, 2006; 177(5): 2760 - 2764.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hamano, A. Asgharpour, S. E. Stroup, T. A. Wynn, E. H. Leiter, and E. Houpt
Resistance of C57BL/6 Mice to Amoebiasis Is Mediated by Nonhemopoietic Cells but Requires Hemopoietic IL-10 Production
J. Immunol., July 15, 2006; 177(2): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. A.F. Hegazi, K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy
Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway
J. Exp. Med., December 19, 2005; 202(12): 1703 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kamada, T. Hisamatsu, S. Okamoto, T. Sato, K. Matsuoka, K. Arai, T. Nakai, A. Hasegawa, N. Inoue, N. Watanabe, et al.
Abnormally Differentiated Subsets of Intestinal Macrophage Play a Key Role in Th1-Dominant Chronic Colitis through Excess Production of IL-12 and IL-23 in Response to Bacteria
J. Immunol., November 15, 2005; 175(10): 6900 - 6908.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Hoentjen, R. B. Sartor, M. Ozaki, and C. Jobin
STAT3 regulates NF-{kappa}B recruitment to the IL-12p40 promoter in dendritic cells
Blood, January 15, 2005; 105(2): 689 - 696.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Van Kampen, J. Gauldie, and S. M. Collins
Proinflammatory properties of IL-4 in the intestinal microenvironment
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G111 - G117.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. J. Mannon, I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al.
Anti-Interleukin-12 Antibody for Active Crohn's Disease
N. Engl. J. Med., November 11, 2004; 351(20): 2069 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. M. Blum, A. Metwali, D. E. Elliott, D. J. Berg, and J. V. Weinstock
CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis
Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G320 - G325.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B Sheil, J McCarthy, L O'Mahony, M W Bennett, P Ryan, J J Fitzgibbon, B Kiely, J K Collins, and F Shanahan
Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis
Gut, May 1, 2004; 53(5): 694 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Liu, B. Hu, D. Xu, and F. Y. Liew
CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-{beta}, and CTLA4
J. Immunol., November 15, 2003; 171(10): 5012 - 5017.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. V. Weinstock, A. Blum, A. Metwali, D. Elliott, N. Bunnett, and R. Arsenescu
Substance P Regulates Th1-Type Colitis in IL-10 Knockout Mice
J. Immunol., October 1, 2003; 171(7): 3762 - 3767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. P. Singh, S. Singh, D. D. Taub, and J. W. Lillard Jr.
Inhibition of IFN-{gamma}-Inducible Protein-10 Abrogates Colitis in IL-10-/- Mice
J. Immunol., August 1, 2003; 171(3): 1401 - 1406.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Tomczak, S. E. Erdman, T. Poutahidis, A. B. Rogers, H. Holcombe, B. Plank, J. G. Fox, and B. H. Horwitz
NF-{kappa}B Is Required Within the Innate Immune System to Inhibit Microflora-Induced Colitis and Expression of IL-12 p40
J. Immunol., August 1, 2003; 171(3): 1484 - 1492.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J McCarthy, L O'Mahony, L O'Callaghan, B Sheil, E E Vaughan, N Fitzsimons, J Fitzgibbon, G C O'Sullivan, B Kiely, J K Collins, et al.
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
Gut, July 1, 2003; 52(7): 975 - 980.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. J. Myers, S. Murthy, A. Flanigan, D. R. Witchell, M. Butler, S. Murray, A. Siwkowski, D. Goodfellow, K. Madsen, and B. Baker
Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-alpha in Two Murine Models of Colitis
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 411 - 424.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter
Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice
Infect. Immun., December 1, 2002; 70(12): 6940 - 6947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr
Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1
J. Biol. Chem., November 8, 2002; 277(46): 43735 - 43740.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Iqbal, J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver
T Helper 1 and T Helper 2 Cells Are Pathogenic in an Antigen-specific Model of Colitis
J. Exp. Med., January 7, 2002; 195(1): 71 - 84.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. C. Kullberg, A. G. Rothfuchs, D. Jankovic, P. Caspar, T. A. Wynn, P. L. Gorelick, A. W. Cheever, and A. Sher
Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation
Infect. Immun., July 1, 2001; 69(7): 4232 - 4241.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. O. Lindsay, C. J. Ciesielski, T. Scheinin, H. J. Hodgson, and F. M. Brennan
The Prevention and Treatment of Murine Colitis Using Gene Therapy with Adenoviral Vectors Encoding IL-10
J. Immunol., June 15, 2001; 166(12): 7625 - 7633.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hong, E. L. Berg, and R. O. Ehrhardt
Persistence of Pathogenic CD4+ Th1-Like Cells In Vivo in the Absence of IL-12 but in the Presence of Autoantigen
J. Immunol., April 1, 2001; 166(7): 4765 - 4772.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Annacker, R. Pimenta-Araujo, O. Burlen-Defranoux, T. C. Barbosa, A. Cumano, and A. Bandeira
CD25+ CD4+ T Cells Regulate the Expansion of Peripheral CD4 T Cells Through the Production of IL-10
J. Immunol., March 1, 2001; 166(5): 3008 - 3018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Fort, R. Lesley, N. J. Davidson, S. Menon, F. Brombacher, M. W. Leach, and D. M. Rennick
IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis
J. Immunol., February 15, 2001; 166(4): 2793 - 2800.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Dieleman, A. Arends, S. L. Tonkonogy, M. S. Goerres, D. W. Craft, W. Grenther, R. K. Sellon, E. Balish, and R. B. Sartor
Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice
Infect. Immun., September 1, 2000; 68(9): 5107 - 5113.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Cong, C. T. Weaver, A. Lazenby, and C. O. Elson
Colitis Induced by Enteric Bacterial Antigen-Specific CD4+ T Cells Requires CD40-CD40 Ligand Interactions for a Sustained Increase in Mucosal IL-12
J. Immunol., August 15, 2000; 165(4): 2173 - 2182.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. M. Wittig, B. Johansson, M. Zoller, C. Schwarzler, and U. Gunthert
Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7)
J. Exp. Med., June 19, 2000; 191(12): 2053 - 2064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. M. Rennick and M. M. Fort
Lessons From Genetically Engineered Animal Models: XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation
Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G829 - G833.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. I. Karachunski, N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine
Absence of IFN-{gamma} or IL-12 Has Different Effects on Experimental Myasthenia Gravis in C57BL/6 Mice
J. Immunol., May 15, 2000; 164(10): 5236 - 5244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Kawachi, S. Jennings, J. Panes, A. Cockrell, F. S. Laroux, L. Gray, M. Perry, H. van der Heyde, E. Balish, D. N. Granger, et al.
Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G734 - G743.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Naiki, H. Nishimura, T. Kawano, Y. Tanaka, S. Itohara, M. Taniguchi, and Y. Yoshikai
Regulatory Role of Peritoneal NK1.1+{alpha}{beta} T Cells in IL-12 Production During Salmonella Infection
J. Immunol., August 15, 1999; 163(4): 2057 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hong, A. Chu, B. R. Ludviksson, E. L. Berg, and R. O. Ehrhardt
IL-12, Independently of IFN-{gamma}, Plays a Crucial Role in the Pathogenesis of a Murine Psoriasis-Like Skin Disorder
J. Immunol., June 15, 1999; 162(12): 7480 - 7491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Schultz, S. L. Tonkonogy, R. K. Sellon, C. Veltkamp, V. L. Godfrey, J. Kwon, W. B. Grenther, E. Balish, I. Horak, and R. B. Sartor
IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1461 - G1472.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. T. Chang, E. M. Shevach, and B. M. Segal
Regulation of Interleukin (IL)-12 Receptor {beta}2 Subunit Expression by Endogenous IL-12: A Critical Step in the Differentiation of Pathogenic Autoreactive T Cells
J. Exp. Med., March 15, 1999; 189(6): 969 - 978.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick
The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men"
Toxicol Pathol, January 1, 1999; 27(1): 123 - 133.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.